ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $27,339,000 | -29.8% | 676,379 | +0.0% | 3.72% | -24.0% |
| Q2 2015 | $38,924,000 | -9.6% | 676,350 | +0.0% | 4.90% | -9.0% |
| Q1 2015 | $43,061,000 | +3.1% | 676,323 | +0.0% | 5.38% | +3.6% |
| Q4 2014 | $41,756,000 | +59.0% | 676,313 | +0.0% | 5.20% | +50.4% |
| Q3 2014 | $26,261,000 | +12.7% | 676,298 | 0.0% | 3.46% | +14.9% |
| Q2 2014 | $23,298,000 | -20.3% | 676,298 | 0.0% | 3.01% | -21.8% |
| Q1 2014 | $29,223,000 | +8.5% | 676,298 | +0.1% | 3.85% | +1.7% |
| Q4 2013 | $26,924,000 | +6.1% | 675,798 | 0.0% | 3.78% | -4.8% |
| Q3 2013 | $25,369,000 | +21.7% | 675,798 | -12.9% | 3.98% | +14.6% |
| Q2 2013 | $20,846,000 | – | 775,798 | – | 3.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |